2019 Effect of Fibroid Location and Size on Efficacy of Elagolix: Results from Phase 3 Clinical Trials ·doi:10.1016/j.jmig.2019.09.666
2019 Phase 3 Trial Results: Efficacy and Safety of Elagolix in a Subset of Women with Uterine Fibroids and Adenomyosis ·doi:10.1016/j.jmig.2019.09.580
2018 Efficacy and safety of elagolix in a subgroup of women with uterine fibroids and adenomyosis: results from a phase 2 trial ·doi:10.1016/j.fertnstert.2018.07.186
2018 Efficacy and Safety of Elagolix in a Subgroup of Women with Uterine Fibroids and Adenomyosis: Results from a Phase 2 Trial ·doi:10.1016/j.jmig.2018.09.175